These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 12147988)

  • 1. Australian states compete for biotech primacy.
    Norrie C
    Nat Biotechnol; 2002 Aug; 20(8):760. PubMed ID: 12147988
    [No Abstract]   [Full Text] [Related]  

  • 2. Surprise US election results may boost biotech.
    Fox JL
    Nat Biotechnol; 2002 Dec; 20(12):1176. PubMed ID: 12454655
    [No Abstract]   [Full Text] [Related]  

  • 3. Sunny outlook for Australian science.
    Pincock S
    Nature; 2009 May; 459(7245):304-5. PubMed ID: 19458676
    [No Abstract]   [Full Text] [Related]  

  • 4. ATP under attack.
    Surendran A
    Nat Biotechnol; 2004 Apr; 22(4):477-8. PubMed ID: 15085806
    [No Abstract]   [Full Text] [Related]  

  • 5. Share slump brings biotech firms to government's door.
    Check E
    Nature; 2003 Jun; 423(6943):908. PubMed ID: 12827159
    [No Abstract]   [Full Text] [Related]  

  • 6. Funding bonanza for astronomy and biotech in Australia.
    Pockley P
    Nature; 2001 Aug; 412(6850):846. PubMed ID: 11528440
    [No Abstract]   [Full Text] [Related]  

  • 7. German regions compete for biotech funds.
    Abbott A; Schiermeir Q
    Nature; 1996 Feb; 379(6568):759. PubMed ID: 8587590
    [No Abstract]   [Full Text] [Related]  

  • 8. Japanese council urges reform of funding system.
    Triendl R
    Nat Biotechnol; 2002 Dec; 20(12):1176-8. PubMed ID: 12454656
    [No Abstract]   [Full Text] [Related]  

  • 9. New tax credit program aims to revive ailing biotech research.
    Clin Transl Sci; 2010 Oct; 3(5):200. PubMed ID: 21500422
    [No Abstract]   [Full Text] [Related]  

  • 10. Maximizing state and federal spending while minimizing conflicts.
    Billingsley ML; Washko M
    Nat Biotechnol; 2006 Dec; 24(12):1473-4. PubMed ID: 17160036
    [No Abstract]   [Full Text] [Related]  

  • 11. Australian biotech suffers growing pains.
    O'Neill G
    Nat Biotechnol; 2005 Apr; 23(4):401-2. PubMed ID: 15815652
    [No Abstract]   [Full Text] [Related]  

  • 12. Do biomaterials really mean business?
    Waltz E
    Nat Biotechnol; 2008 Aug; 26(8):851-3. PubMed ID: 18688229
    [No Abstract]   [Full Text] [Related]  

  • 13. Translational science: a view from a biotechnology investor.
    Klausner R
    Sci Transl Med; 2010 Jun; 2(34):34ed3. PubMed ID: 20519715
    [No Abstract]   [Full Text] [Related]  

  • 14. New Zealand launches biotech seed fund.
    Griggs K
    Nat Biotechnol; 2004 Apr; 22(4):480-1. PubMed ID: 15085809
    [No Abstract]   [Full Text] [Related]  

  • 15. Basic research: goddess and cow.
    Nichols RW
    Nature; 2010 Sep; 467(7314):400. PubMed ID: 20864981
    [No Abstract]   [Full Text] [Related]  

  • 16. Science and politics: a fatal mix?
    Joachim C
    Nat Mater; 2004 Jul; 3(7):416. PubMed ID: 15229483
    [No Abstract]   [Full Text] [Related]  

  • 17. Recession Watch: Learn to convince politicians.
    Taylor I
    Nature; 2009 Feb; 457(7232):958-9. PubMed ID: 19225499
    [No Abstract]   [Full Text] [Related]  

  • 18. Responding to stimuli.
    Mahapatra A
    ACS Chem Biol; 2009 Apr; 4(4):233. PubMed ID: 19371128
    [No Abstract]   [Full Text] [Related]  

  • 19. Plan for $100m boost to Israeli biotech comes under threat.
    Watzman H
    Nature; 1998 Mar; 392(6672):117. PubMed ID: 9515950
    [No Abstract]   [Full Text] [Related]  

  • 20. Why aren't there more scientists advocating for funding?
    Wells RD; Farnham P
    Science; 2006 Nov; 314(5802):1081. PubMed ID: 17110554
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.